English

ACUTUS MEDICAL, INC.

EDGAR

AFIB Annual report (10-K) · filed 2025-03-24

Annual consolidated revenue for 2024: about USD 20.16M, using the latest reported figures. The previous period, 2023, was about USD 7.164M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

7.13 million USD

2024 Q4 · USD

Exact inputs and evidence

Revenue: 20157000 USD Source
Revenue: 13027000 USD Source

Operating margin

-3.94%

2024 Q4 · %

Exact inputs and evidence

Operating Income: -57000 USD Source
Operating Income: 224000 USD Source
Revenue: 20157000 USD Source
Revenue: 13027000 USD Source

Operating cash flow

-4.06 million USD

2024 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -31660000 USD Source
Operating Cash Flow: -27602000 USD Source

Cash and cash equivalents: 14 million USD 2024-12-31 Source
Exact value

14019000 USD
Long-term debt including current maturities: 32.6 million USD 2024-12-31 Source
Exact value

32569000 USD
Shares outstanding: 29.9 million shares 2024-12-31 Source
Exact value

29912305 shares

Reported share-count change

2.04% · 599 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

29313667 shares · 2023-12-31· Source
29912305 shares · 2024-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

20.1 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Revenue: 3625000 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 4127000 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 5266000 USD · 2024-07-01 – 2024-09-30 Source
Revenue: 20157000 USD · 2024-01-01 – 2024-12-31 Source
Revenue: 13027000 USD · 2024-01-01 – 2024-09-30 Source

Net income

-9.55 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Net income: -1620000 USD · 2024-01-01 – 2024-03-31 Source
Net income: -914000 USD · 2024-04-01 – 2024-06-30 Source
Net income: -5607000 USD · 2024-07-01 – 2024-09-30 Source
Net income: -9547000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -8141000 USD · 2024-01-01 – 2024-09-30 Source

Operating cash flow

-31.7 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Operating cash flow: -16929000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -23904000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -16929000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -27602000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -23904000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -31660000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -27602000 USD · 2024-01-01 – 2024-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-03-24.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2024-12-31
Operating income: 6 of 11 periods available· newest 2024-12-31
Net income: 6 of 11 periods available· newest 2024-12-31
Operating cash flow: 6 of 11 periods available· newest 2024-12-31
Capital expenditure: 6 of 11 periods available· newest 2024-12-31
Total assets: 6 of 11 periods available· newest 2024-12-31
Total liabilities: 6 of 11 periods available· newest 2024-12-31
Current assets: 6 of 11 periods available· newest 2024-12-31
Current liabilities: 6 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2024-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2024-12-31
Shares outstanding: 6 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+181.4%

Prior period

USD 7.16 million

2023-01-01 – 2023-12-31
Current period

USD 20.16 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

20157000 − 7164000 = 12993000 USD

7164000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
20157000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Year-over-year change in Revenue: 12993000 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 20157000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#1024111 Filing: 000162828025014559 Input fundies:Revenue: 7164000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#1025125 Filing: 000162828025014559
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 72.12 million

Prior period

−USD 81.66 million

2023-01-01 – 2023-12-31
Current period

−USD 9.55 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-9547000 − -81663000 = 72116000 USD

-81663000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-9547000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Year-over-year change in Net income: 72116000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -9547000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#884622 Filing: 000162828025014559 Input fundies:NetIncome: -81663000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#885406 Filing: 000162828025014559
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 31.46 million

Prior period

−USD 63.12 million

2023-01-01 – 2023-12-31
Current period

−USD 31.66 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-31660000 − -63118000 = 31458000 USD

-63118000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-31660000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Year-over-year change in Operating cash flow: 31458000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -31660000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#915021 Filing: 000162828025014559 Input fundies:OperatingCashFlow: -63118000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#915685 Filing: 000162828025014559
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-48.9%

Prior period

USD 219,000

2023-01-01 – 2023-12-31
Current period

USD 112,000

2024-01-01 – 2024-12-31

Exact inputs and evidence

112000 − 219000 = -107000 USD

219000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
112000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Year-over-year change in Capital expenditure: -107000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 112000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#923080 Filing: 000162828025014559 Input fundies:CapitalExpenditure: 219000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#923645 Filing: 000162828025014559
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 20.16 million 100% of revenue
Cost of revenue USD 19.14 million 95% of revenue
Operating expenses USD 1.07 million 5.3% of revenue
Operating income −USD 57,000 −0.3% of revenue
Tax, interest and other Derived USD 9.49 million 47% of revenue
Net income −USD 9.55 million −47% of revenue

Cash

Operating cash flow −USD 31.66 million −157% of revenue
Capital expenditure USD 112,000 0.6% of revenue
Free cash flow Derived −USD 31.77 million −158% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 2,659% of revenue.
2020 Operating loss: operating costs were 1,179% of revenue.
2021 Operating loss: operating costs were 749% of revenue.
2022 Net loss: net income was −1,307% of revenue.
2023 Operating loss: operating costs were 264% of revenue.
2024 Operating loss: operating costs were 100% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	2836000	75405000 Derived	-72569000	24470000 Derived	-97039000	-59381000 Derived	Source 2019-01-01 – 2019-12-31: 2836000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -72569000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -97039000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -55986000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3395000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	8464000	99797000 Derived	-91333000	10667000 Derived	-102000000	-96425000 Derived	Source 2020-01-01 – 2020-12-31: 8464000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -91333000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -102000000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -85200000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 11225000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	17263000	129385000 Derived	-112122000	5578000 Derived	-117700000	-109673000 Derived	Source 2021-01-01 – 2021-12-31: 17263000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -112122000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -117700000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -99700000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 9973000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	3031000	-38012000 Derived	41043000	80659000 Derived	-39616000	-89145000 Derived	Source 2022-01-01 – 2022-12-31: 3031000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 41043000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -39616000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -88917000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 228000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	7164000	18892000 Derived	-11728000	69935000 Derived	-81663000	-63337000 Derived	Source 2023-01-01 – 2023-12-31: 7164000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -11728000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -81663000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -63118000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 219000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	20157000	20214000 Derived	-57000	9490000 Derived	-9547000	-31772000 Derived	Source 2024-01-01 – 2024-12-31: 20157000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -57000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -9547000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -31660000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 112000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 20.2M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	2836000	Revenue: 2836000 Open source
20202020-12-31	Revenue	8464000	Revenue: 8464000 Open source
20212021-12-31	Revenue	17263000	Revenue: 17263000 Open source
20222022-12-31	Revenue	3031000	Revenue: 3031000 Open source
20232023-12-31	Revenue	7164000	Revenue: 7164000 Open source
20242024-12-31	Revenue	20157000	Revenue: 20157000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

181.4% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 2836000 Open source
20202020-12-31	Year over year	198.4%	Revenue: 8464000 Open source Revenue: 2836000 Open source
20212021-12-31	Year over year	104%	Revenue: 17263000 Open source Revenue: 8464000 Open source
20222022-12-31	Year over year	-82.4%	Revenue: 3031000 Open source Revenue: 17263000 Open source
20232023-12-31	Year over year	136.4%	Revenue: 7164000 Open source Revenue: 3031000 Open source
20242024-12-31	Year over year	181.4%	Revenue: 20157000 Open source Revenue: 7164000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -0.3% 2024

Net margin -47.4% 2024

Free cash flow margin -157.6% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-2,558.9%	Operating Income: -72569000 Open source Revenue: 2836000 Open source
20202020-12-31	Operating margin	-1,079.1%	Operating Income: -91333000 Open source Revenue: 8464000 Open source
20212021-12-31	Operating margin	-649.5%	Operating Income: -112122000 Open source Revenue: 17263000 Open source
20222022-12-31	Operating margin	1,354.1%	Operating Income: 41043000 Open source Revenue: 3031000 Open source
20232023-12-31	Operating margin	-163.7%	Operating Income: -11728000 Open source Revenue: 7164000 Open source
20242024-12-31	Operating margin	-0.3%	Operating Income: -57000 Open source Revenue: 20157000 Open source
20192019-12-31	Net margin	-3,421.7%	Net Income: -97039000 Open source Revenue: 2836000 Open source
20202020-12-31	Net margin	-1,205.1%	Net Income: -102000000 Open source Revenue: 8464000 Open source
20212021-12-31	Net margin	-681.8%	Net Income: -117700000 Open source Revenue: 17263000 Open source
20222022-12-31	Net margin	-1,307%	Net Income: -39616000 Open source Revenue: 3031000 Open source
20232023-12-31	Net margin	-1,139.9%	Net Income: -81663000 Open source Revenue: 7164000 Open source
20242024-12-31	Net margin	-47.4%	Net Income: -9547000 Open source Revenue: 20157000 Open source
20192019-12-31	Free cash flow margin	-2,093.8%	Revenue: 2836000 Open source Operating Cash Flow: -55986000 Open source Capital Expenditure: 3395000 Open source
20202020-12-31	Free cash flow margin	-1,139.2%	Revenue: 8464000 Open source Operating Cash Flow: -85200000 Open source Capital Expenditure: 11225000 Open source
20212021-12-31	Free cash flow margin	-635.3%	Revenue: 17263000 Open source Operating Cash Flow: -99700000 Open source Capital Expenditure: 9973000 Open source
20222022-12-31	Free cash flow margin	-2,941.1%	Revenue: 3031000 Open source Operating Cash Flow: -88917000 Open source Capital Expenditure: 228000 Open source
20232023-12-31	Free cash flow margin	-884.1%	Revenue: 7164000 Open source Operating Cash Flow: -63118000 Open source Capital Expenditure: 219000 Open source
20242024-12-31	Free cash flow margin	-157.6%	Revenue: 20157000 Open source Operating Cash Flow: -31660000 Open source Capital Expenditure: 112000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -31.7M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-55986000	Operating Cash Flow: -55986000 Open source
20202020-12-31	Operating cash flow	-85200000	Operating Cash Flow: -85200000 Open source
20212021-12-31	Operating cash flow	-99700000	Operating Cash Flow: -99700000 Open source
20222022-12-31	Operating cash flow	-88917000	Operating Cash Flow: -88917000 Open source
20232023-12-31	Operating cash flow	-63118000	Operating Cash Flow: -63118000 Open source
20242024-12-31	Operating cash flow	-31660000	Operating Cash Flow: -31660000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -31.8M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-59381000	Operating Cash Flow: -55986000 Open source Capital Expenditure: 3395000 Open source
20202020-12-31	Free cash flow	-96425000	Operating Cash Flow: -85200000 Open source Capital Expenditure: 11225000 Open source
20212021-12-31	Free cash flow	-109673000	Operating Cash Flow: -99700000 Open source Capital Expenditure: 9973000 Open source
20222022-12-31	Free cash flow	-89145000	Operating Cash Flow: -88917000 Open source Capital Expenditure: 228000 Open source
20232023-12-31	Free cash flow	-63337000	Operating Cash Flow: -63118000 Open source Capital Expenditure: 219000 Open source
20242024-12-31	Free cash flow	-31772000	Operating Cash Flow: -31660000 Open source Capital Expenditure: 112000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

140.5% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Liabilities / assets	73.9%	Total Liabilities: 77908000 Open source Total Assets: 105455000 Open source
20202020-12-31	Liabilities / assets	34.3%	Total Liabilities: 65952000 Open source Total Assets: 192535000 Open source
20212021-12-31	Liabilities / assets	37.7%	Total Liabilities: 64066000 Open source Total Assets: 169792000 Open source
20222022-12-31	Liabilities / assets	43.8%	Total Liabilities: 58421000 Open source Total Assets: 133440000 Open source
20232023-12-31	Liabilities / assets	101.6%	Total Liabilities: 54839000 Open source Total Assets: 53960000 Open source
20242024-12-31	Liabilities / assets	140.5%	Total Liabilities: 40240000 Open source Total Assets: 28648000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.06× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Current assets / current liabilities	2.58×	Current Assets: 82456000 Open source Current Liabilities: 31910000 Open source
20202020-12-31	Current assets / current liabilities	6.91×	Current Assets: 151388000 Open source Current Liabilities: 21907000 Open source
20212021-12-31	Current assets / current liabilities	6.82×	Current Assets: 126290000 Open source Current Liabilities: 18510000 Open source
20222022-12-31	Current assets / current liabilities	5.93×	Current Assets: 117867000 Open source Current Liabilities: 19872000 Open source
20232023-12-31	Current assets / current liabilities	2.44×	Current Assets: 46252000 Open source Current Liabilities: 18942000 Open source
20242024-12-31	Current assets / current liabilities	2.06×	Current Assets: 25578000 Open source Current Liabilities: 12438000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 97.04 million Exact value Exact value: -97039000 USD 2019-01-01 – 2019-12-31: -97039000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACUTUS MEDICAL, INC. · 2019-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Net Income: -97039000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -97039000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000156459021014208/afib-20201231.xml#265312 Filing: 000156459021014208 The citation records this snapshot. The page link may show a newer release later.	−USD 55.99 million Exact value Exact value: -55986000 USD 2019-01-01 – 2019-12-31: -55986000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACUTUS MEDICAL, INC. · 2019-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Operating Cash Flow: -55986000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -55986000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000156459021014208/afib-20201231.xml#295136 Filing: 000156459021014208 The citation records this snapshot. The page link may show a newer release later.	USD 3.4 million Exact value Exact value: 3395000 USD 2019-01-01 – 2019-12-31: 3395000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACUTUS MEDICAL, INC. · 2019-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Capital Expenditure: 3395000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3395000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000156459021014208/afib-20201231.xml#296755 Filing: 000156459021014208 The citation records this snapshot. The page link may show a newer release later.	−USD 59.38 million Calculation and evidence -55986000 − 3395000 USD Exact free cash flow: -59381000 USD 2019-01-01 – 2019-12-31: -55986000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3395000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACUTUS MEDICAL, INC. · 2019-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Free cash flow: -59381000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -55986000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000156459021014208/afib-20201231.xml#295136 Filing: 000156459021014208 Input fundies:CapitalExpenditure: 3395000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000156459021014208/afib-20201231.xml#296755 Filing: 000156459021014208 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 102 million Exact value Exact value: -102000000 USD 2020-01-01 – 2020-12-31: -102000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACUTUS MEDICAL, INC. · 2020-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Net Income: -102000000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -102000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828022014143/afib-20220331.htm#578316 Filing: 000162828022014143 The citation records this snapshot. The page link may show a newer release later.	−USD 85.2 million Exact value Exact value: -85200000 USD 2020-01-01 – 2020-12-31: -85200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACUTUS MEDICAL, INC. · 2020-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Operating Cash Flow: -85200000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -85200000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828022007921/afib-20211231.htm#1514452 Filing: 000162828022007921 The citation records this snapshot. The page link may show a newer release later.	USD 11.23 million Exact value Exact value: 11225000 USD 2020-01-01 – 2020-12-31: 11225000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACUTUS MEDICAL, INC. · 2020-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Capital Expenditure: 11225000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11225000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828022007921/afib-20211231.htm#1444701 Filing: 000162828022007921 The citation records this snapshot. The page link may show a newer release later.	−USD 96.43 million Calculation and evidence -85200000 − 11225000 USD Exact free cash flow: -96425000 USD 2020-01-01 – 2020-12-31: -85200000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 11225000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACUTUS MEDICAL, INC. · 2020-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Free cash flow: -96425000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -85200000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828022007921/afib-20211231.htm#1514452 Filing: 000162828022007921 Input fundies:CapitalExpenditure: 11225000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828022007921/afib-20211231.htm#1444701 Filing: 000162828022007921 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 117.7 million Exact value Exact value: -117700000 USD 2021-01-01 – 2021-12-31: -117700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACUTUS MEDICAL, INC. · 2021-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Net Income: -117700000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -117700000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828023009077/afib-20221231.htm#1415653 Filing: 000162828023009077 The citation records this snapshot. The page link may show a newer release later.	−USD 99.7 million Exact value Exact value: -99700000 USD 2021-01-01 – 2021-12-31: -99700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACUTUS MEDICAL, INC. · 2021-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Operating Cash Flow: -99700000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -99700000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828023009077/afib-20221231.htm#1416206 Filing: 000162828023009077 The citation records this snapshot. The page link may show a newer release later.	USD 9.97 million Exact value Exact value: 9973000 USD 2021-01-01 – 2021-12-31: 9973000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACUTUS MEDICAL, INC. · 2021-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Capital Expenditure: 9973000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9973000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828023009077/afib-20221231.htm#1359617 Filing: 000162828023009077 The citation records this snapshot. The page link may show a newer release later.	−USD 109.67 million Calculation and evidence -99700000 − 9973000 USD Exact free cash flow: -109673000 USD 2021-01-01 – 2021-12-31: -99700000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 9973000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACUTUS MEDICAL, INC. · 2021-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Free cash flow: -109673000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -99700000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828023009077/afib-20221231.htm#1416206 Filing: 000162828023009077 Input fundies:CapitalExpenditure: 9973000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828023009077/afib-20221231.htm#1359617 Filing: 000162828023009077 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 39.62 million Exact value Exact value: -39616000 USD 2022-01-01 – 2022-12-31: -39616000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACUTUS MEDICAL, INC. · 2022-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Net Income: -39616000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39616000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014036/afib-20231231.htm#1018068 Filing: 000162828024014036 The citation records this snapshot. The page link may show a newer release later.	−USD 88.92 million Exact value Exact value: -88917000 USD 2022-01-01 – 2022-12-31: -88917000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACUTUS MEDICAL, INC. · 2022-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Operating Cash Flow: -88917000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -88917000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014036/afib-20231231.htm#1058171 Filing: 000162828024014036 The citation records this snapshot. The page link may show a newer release later.	USD 228,000 Exact value Exact value: 228000 USD 2022-01-01 – 2022-12-31: 228000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACUTUS MEDICAL, INC. · 2022-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Capital Expenditure: 228000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 228000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014036/afib-20231231.htm#1066164 Filing: 000162828024014036 The citation records this snapshot. The page link may show a newer release later.	−USD 89.15 million Calculation and evidence -88917000 − 228000 USD Exact free cash flow: -89145000 USD 2022-01-01 – 2022-12-31: -88917000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 228000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACUTUS MEDICAL, INC. · 2022-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Free cash flow: -89145000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -88917000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014036/afib-20231231.htm#1058171 Filing: 000162828024014036 Input fundies:CapitalExpenditure: 228000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014036/afib-20231231.htm#1066164 Filing: 000162828024014036 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 81.66 million Exact value Exact value: -81663000 USD 2023-01-01 – 2023-12-31: -81663000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACUTUS MEDICAL, INC. · 2023-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Net Income: -81663000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -81663000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#885406 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.	−USD 63.12 million Exact value Exact value: -63118000 USD 2023-01-01 – 2023-12-31: -63118000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACUTUS MEDICAL, INC. · 2023-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Operating Cash Flow: -63118000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -63118000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#915685 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.	USD 219,000 Exact value Exact value: 219000 USD 2023-01-01 – 2023-12-31: 219000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACUTUS MEDICAL, INC. · 2023-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Capital Expenditure: 219000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 219000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#923645 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.	−USD 63.34 million Calculation and evidence -63118000 − 219000 USD Exact free cash flow: -63337000 USD 2023-01-01 – 2023-12-31: -63118000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 219000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACUTUS MEDICAL, INC. · 2023-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Free cash flow: -63337000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -63118000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#915685 Filing: 000162828025014559 Input fundies:CapitalExpenditure: 219000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#923645 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 9.55 million Exact value Exact value: -9547000 USD 2024-01-01 – 2024-12-31: -9547000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Net Income: -9547000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9547000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#884622 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.	−USD 31.66 million Exact value Exact value: -31660000 USD 2024-01-01 – 2024-12-31: -31660000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Operating Cash Flow: -31660000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31660000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#915021 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.	USD 112,000 Exact value Exact value: 112000 USD 2024-01-01 – 2024-12-31: 112000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Capital Expenditure: 112000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 112000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#923080 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.	−USD 31.77 million Calculation and evidence -31660000 − 112000 USD Exact free cash flow: -31772000 USD 2024-01-01 – 2024-12-31: -31660000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 112000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACUTUS MEDICAL, INC. · 2024-12-31 ACUTUS MEDICAL, INC. (edgar:1522860) Free cash flow: -31772000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T04:05:00Z Snapshot: a11a04b2abe92e22e7d7549e7f2db7d453b2d2953193230c04088ee8060a3d4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1522860?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31660000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#915021 Filing: 000162828025014559 Input fundies:CapitalExpenditure: 112000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1522860/000162828025014559/afib-20241231.htm#923080 Filing: 000162828025014559 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

23 filings · 1,806 latest values · 1,806 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001522860, 1522860, AFIB, edgar:1522860

Also known as ACUTUS MEDICAL, INC., Acutus Medical, Inc.

ACUTUS MEDICAL, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation